Figure 1From: Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretroviralsDistribution of steatosis according to fibrosis index in 184 HIV-HCV coinfected patients treated with antiretroviral therapy. Steatosis is defined as mild (<33% of hepatocytes affected) or severe (>33% of hepatocytes affected).Back to article page